Nectar Lifesciences Limited (BOM:532649)
India flag India · Delayed Price · Currency is INR
10.63
+0.37 (3.61%)
At close: Aug 21, 2026

Nectar Lifesciences Cash Flow Statement

Millions INR. Fiscal year is Apr - Mar.

Operating Activities

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Net Income
-2,929-1,13749.95-241.83250.47
Depreciation & Amortization
228.03623.89607.18591.19569.68
Loss (Gain) From Sale of Assets
-114.990.14--404.08-94.07
Loss (Gain) From Sale of Investments
520.95-0.35-1.8-1.05-0.03
Provision & Write-off of Bad Debts
-98.6716.089.332.239.65
Other Operating Activities
2,223271.92893.53610.79859.77
Change in Accounts Receivable
3,160----
Change in Inventory
2,329----
Change in Accounts Payable
-3,417----
Change in Other Net Operating Assets
-12.271,920688.67779.26-645.42
Operating Cash Flow
-3,4871,6942,2471,337950.05
Operating Cash Flow Growth
--24.59%68.11%40.68%344.38%

Investing Activities

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Capital Expenditures
-122.74-437.95-294.15-300.6-249.7
Sale of Property, Plant & Equipment
204.580.08-797.88397.31
Cash Acquisitions
32.37----
Divestitures
12,540----
Investment in Securities
-645.37--2.5-
Other Investing Activities
72.818.57123.917.2618.83
Investing Cash Flow
12,081-419.3-170.25517.04166.44

Financing Activities

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Short-Term Debt Issued
-279.97---
Long-Term Debt Issued
--4.120.011,568
Total Debt Issued
-279.974.120.011,568
Short-Term Debt Repaid
-4,402--466.94-438.58-2,063
Long-Term Debt Repaid
-1,962-815.11-720.11-652.39-10.28
Total Debt Repaid
-6,364-815.11-1,187-1,091-2,073
Net Debt Issued (Repaid)
-6,364-535.14-1,183-1,091-505.69
Repurchase of Common Stock
-810----
Other Financing Activities
-491.25-745.78-871.42-764.87-688.11
Financing Cash Flow
-7,665-1,281-2,054-1,856-1,194

Net Cash Flow

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Net Cash Flow
929.13-5.8422.26-2.28-77.31

Free Cash Flow

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Free Cash Flow
-3,6101,2561,9531,036700.35
Free Cash Flow Growth
--35.66%88.50%47.91%-
Free Cash Flow Margin
-7.52%11.59%6.80%4.20%
Free Cash Flow Per Share
-16.525.608.714.623.12
Levered Free Cash Flow
5,402-171.02970.9259.57-492.06
Unlevered Free Cash Flow
5,628310.571,531777.06-54.91

Additional Metrics

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash Interest Paid
361.25745.78871.42794.87788.1
Change in Working Capital
2,0591,920688.67779.26-645.42